Connect with us

Health

Commission authorises Chikungunya vaccine for adults and adolescents

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

The Commission has authorized a vaccine against the chikungunya virus for adults and young people aged 12 and over. This follows the authorization of the vaccine for adults in 2024, which protects against the chikungunya virus, transmitted by infected mosquitoes.

Although the virus is not endemic in the EU, the effects of climate change have led to an increased presence of mosquitoes that transmit serious diseases. Most cases of the chikungunya virus concern travellers infected outside Europe. The European Centre for Disease Prevention and Control (ECDC) reports that in 2024, 620,000 cases of the chikungunya virus and 213 deaths were detected from countries in the Americas, Asia, Africa and Europe.

This authorisation reflects the EU's One Health approach to combating vector-borne infectious diseases. It was unanimously approved by member states following a rigorous assessment by the European Medicines Agency (EMA). It is up to the national authorities in each member state to decide who will have access to the vaccine, taking into account the national situation and the level of risk.

Health and Animal Welfare Commissioner Olivér Várhelyi (pictured) said: "Today's authorisation of a vaccine against chikungunya in the EU for both adults and adolescents is welcome news. The Commission is determined to use all the tools at our disposal to tackle the public health risks posed by infected mosquitoes and to protect our citizens. This is the European Health Union."

Share this article:

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending